BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2590056)

  • 21. Cancer of the laryngeal vestibule. A retrospective study of 161 cases.
    Guerrier B; Balmigere G; Daures JP; Lallemant JG; Guerrier Y
    Arch Otorhinolaryngol; 1989; 246(5):378-81. PubMed ID: 2590055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
    Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx.
    Robbins KT; Davidson W; Peters LJ; Goepfert H
    Arch Otolaryngol Head Neck Surg; 1988 Apr; 114(4):421-6. PubMed ID: 3348897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gregorio Marañón Hospital experience with vertical partial laryngectomies.
    Scola B; Fernández-Vega M; Martinez T; Scola E; Fernández-Vega S; Ramírez C
    Eur Arch Otorhinolaryngol; 1999; 256(6):296-8. PubMed ID: 10456278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment and prognosis of stage T3 glottic laryngeal cancer--a report of 65 cases].
    Yu WB; Zeng ZY; Chen FJ; Peng HW
    Ai Zheng; 2006 Jan; 25(1):85-7. PubMed ID: 16405757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
    Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
    Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
    Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
    Shimm DS; Coulthard SW
    Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Function preserving laryngeal cancer surgery in Hungary-- a historical retrospect and 25 years personal experiences].
    Czigner J
    Laryngorhinootologie; 1993 Sep; 72(9):417-20. PubMed ID: 8240630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of T3 carcinoma of the larynx by surgery or radiotherapy.
    Jones AS; Cook JA; Phillips DE; Soler Lluch E
    Clin Otolaryngol Allied Sci; 1992 Oct; 17(5):433-6. PubMed ID: 1458627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure.
    Li M; Lorenz RR; Khan MJ; Burkey BB; Adelstein DJ; Greskovich JF; Koyfman SA; Scharpf J
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):245-51. PubMed ID: 23585149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles?
    Groome PA; O'Sullivan B; Irish JC; Rothwell DM; Math KS; Bissett RJ; Dixon PR; Eapen LJ; Gulavita SP; Hammond JA; Hodson DI; Mackenzie RG; Schneider KM; Warde PR; Mackillop WJ
    J Clin Epidemiol; 2001 Mar; 54(3):301-15. PubMed ID: 11223328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with radical resection of the larynx in stage III - IV cancer].
    Rzaev RM
    Vestn Otorinolaringol; 1993; (5-6):36-9. PubMed ID: 8009769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial laryngectomy for recurrent laryngeal carcinoma.
    Watters GW; Patel SG; Rhys-Evans PH
    Clin Otolaryngol Allied Sci; 2000 Apr; 25(2):146-52. PubMed ID: 10816221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The place of partial laryngectomy in the treatment of laryngeal cancer--a view from the U.K.
    Shaw HJ
    Auris Nasus Larynx; 1985; 12 Suppl 2():S182-90. PubMed ID: 3836639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease.
    Buglione M; Pedretti S; Costa L; Foscarini F; Maddalo M; Pegurri L; Pasinetti N; Ciccarelli S; Tonoli S; Magrini SM
    Radiol Med; 2015 Nov; 120(11):1071-7. PubMed ID: 25820354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical margin to direct the treatment and predict the prognosis of laryngeal carcinoma after partial laryngectomy].
    Xu GP; Zeng ZY; Xia LP; Chen FJ; Guo ZM; Zhang Q
    Ai Zheng; 2002 Feb; 21(2):200-3. PubMed ID: 12479077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The results of treatment of laryngeal cancer in 30-year material of General Hospital in Zielona Góra].
    Dutkiewicz W; Jankowska-Kuc M; Jabłońska M
    Otolaryngol Pol; 2000; 54 Suppl 31():245-7. PubMed ID: 10974898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparison of the therapeutic effect between preoperative radiotherapy plus operation and operation alone for laryngocarcinoma. A prospective study of 260 cases].
    Li GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(3):170-3, 188. PubMed ID: 8217301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.